Dementia vs. Alzheimer’s

This month's MedEvidence guest, Dr. Steven Toenjes, MD, a board-certified neurologist, former staff neurologist in the U.S. Navy and an award-winning director of neurology residents at the Uniformed Services University of Health Sciences and decorated Navy veteran joins Dr. Michael Koren, MD and Michelle McCormick to discuss Alzheimer's disease in a four-part series.

With over six million Americans believed to have Alzheimer's disease and the sixth leading cause of death in the United States, MedEvidence breaks down Dementia vs. Alzheimer's, including diagnosis and treatments.

• Part 1: Dementia vs. Alzheimer's What's the same and what's different?
• Part 2: Is It Alzheimer's or Something Else? Drs. Toenjes and Koren answer the famous question "When do you know something is wrong? Followed by explaining amyloid proteins, DNA structure, Alzheimer's therapy, and the research behind it.
• Part 3: The Hullabaloos of Aduhelm! What's all the hullabaloos about Aduhelm, the first new Alzheimer's drug approval since 2003? In this episode Dr. Steven Toenjes, MD, a board-certified neurologist, former staff neurologist in the U.S. Navy, and an award-winning director of neurology residents at the Uniformed Services University of Health Sciences and decorated Navy veteran joins Dr. Michael Koren and Michelle McCormick to discuss the first new Alzheimer's drug approval since 2003 and the controversy over FDA's approval of Biogen's Aducanumab (Aduhelm). 
• Part 4: The Future of Alzheimer's Research and what your gut has to do with Alzheimer's.

Free Memory Screening

Be a part of advancing science by participating in research.

Music: Storyblocks - Corporate Inspired

Recorded Date: March 11, 2022